FDA Warns Of Potential Risk From Hologic Soft Tissue Devices

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland

The Food and Drug Administration (FDA) has issued a warning regarding potential risks associated with medical devices manufactured by Hologic that are implanted in soft tissue. The FDA's alert comes after reports of adverse events linked to these devices.

Hologic is a leading provider of medical devices, including those used in soft tissue procedures. The FDA's warning specifically focuses on the safety of Hologic's soft tissue devices and urges healthcare providers to closely monitor patients who have received these implants.